摘要
目的从胃癌细胞MGC803克隆并在体外表达血管内皮细胞生长因子(VEGF),利用VEGF121单克隆抗体对其产物进行鉴定,为进一步明确肿瘤组织中VEGF来源,并以VEGF为靶点治疗肿瘤奠定基础。方法用杂交瘤技术制备VEGF121单克隆抗体(McAb),通过ELISA、3HTdR掺入检测其活性;用RTPCR从MGC803细胞克隆VEGF基因,与原核表达载体PGEX2T重组,在大肠杆菌中进行表达,以Westernblot对表达产物进行鉴定。结果所制备的VEGFMcAb能特异性地同VEGF结合,并能中和VEGF对内皮细胞的促增殖作用;利用RTPCR扩增出特异的VEGF基因片段,重组到PGEX2T表达载体中,在大肠杆菌XL1blue中得到了稳定高效表达的蛋白产物,并能特异性地被VEGF抗体所识别。结论在MGC803细胞中存在VEGFmRNA表达,提示肿瘤细胞是肿瘤组织中VEGF的重要来源。VEGFMcAb不仅可对其存在进行检测,而且可有效抑制VEGF对内皮细胞的促增殖作用。
Objective To further elucidate the source of VEGF in solid tumors. Methods Traditional hybridoma technology was used to prepare VEGF monoclonal antibodies (McAb); It's activity was measured by 3 H TdR incorporation on human umbilical vein endothelial cells (HUVEC). VEGF gene was amplified by PCR with cDNA as template from MGC803 cell lines. The PCR products were cloned into fusion protein prokaryotic expression vector PGEX2T which expressed in E.coli XL 1blue. Western blot analysis was used to identify expression of VEGF. Results The McAbs could specifically bind to VEGF in ELISA. One of the McAbs(5C 5) could neutralize the mitogenic activity of VEGF 121 on HUVEC in a dose dependent manner. The VEGF gene fragment obtained from RT PCR cloned to PGEX2T vector expressed a protein product which reacted specifically with McAb 5C 5. Conclusion Gastric carcinoma is shown to express VEGF. It may be a major source of VEGF in human solid tumor. Monoclonal antibody against VEGF may be of value in the treatment of cancer.
出处
《中华肿瘤杂志》
CAS
CSCD
北大核心
1999年第2期93-95,共3页
Chinese Journal of Oncology
基金
国家"九五"
863高技术项目
关键词
胃肿瘤
VEGF
单克隆抗体
制备
鉴定
Stomach neoplasms Vascular endothelial growth factor Antibodies, monoclonal